pegvaliase (Palynziq) Report issue

Biologics Recombinant protein Orphan Drug FDA Approved FDA Fast Track FDA
AACT DrugBank Drugs@FDA PubChem
Back

Drug Pricing Summary

VA Big4

$181.0400 - $379.5280

VA FSS

$243.6150 - $487.2300

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
pegvaliase 10 mg / 0.5 mL (0.5 mL INJECTION) $181.2250 VA Big4
  • Palynziq (2)
    		•  BioMarin Pharmaceutical, Inc.
    pegvaliase 10 mg / 0.5 mL (0.5 mL INJECTION) $243.6150 VA FSS
  • Palynziq (2)
    		•  BioMarin Pharmaceutical, Inc.
    pegvaliase 20 mg / 1 mL (1 mL INJECTION) $360.7000 VA Big4
  • Palynziq (1)
    		•  BioMarin Pharmaceutical, Inc.
    pegvaliase 20 mg / 1 mL (1 mL INJECTION) $379.5280 VA Big4
  • Palynziq (10)
    		•  BioMarin Pharmaceutical, Inc.
    pegvaliase 20 mg / 1 mL (1 mL INJECTION) $487.2280 VA FSS
  • Palynziq (10)
    		•  BioMarin Pharmaceutical, Inc.
    pegvaliase 20 mg / 1 mL (1 mL INJECTION) $487.2300 VA FSS
  • Palynziq (1)
    		•  BioMarin Pharmaceutical, Inc.
    pegvaliase 2.5 mg / 0.5 mL (0.5 mL INJECTION) $181.0400 VA Big4
  • Palynziq (2)
    		•  BioMarin Pharmaceutical, Inc.
    pegvaliase 2.5 mg / 0.5 mL (0.5 mL INJECTION) $243.6150 VA FSS
  • Palynziq (2)
    		•  BioMarin Pharmaceutical, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue